ストックスクリーナーアプリを入手
3.48
2.05%
0.07
前日終値:
$3.41
開ける：
$3.41
24時間の取引高:
218.32K
Relative Volume:
0.31
時価総額：
$437.53M
収益：
$433.14M
当期純損益:
$4.95M
株価収益率:
97.48
EPS:
0.0357
ネットキャッシュフロー:
$6.55M
1週間 パフォーマンス:
-2.25%
1か月 パフォーマンス:
+12.26%
6か月 パフォーマンス:
+30.83%
1年 パフォーマンス:
+4.50%
1日の値動き範囲:
$3.40
$3.5399
1週間の範囲:
$3.40
$3.85
52週間の値動き範囲:
$2.165
$4.57
Organogenesis Holdings Inc Stock (ORGO) Company Profile
ORGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.48 | 437.53M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
172.24 | 77.71B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.52 | 43.05B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.32 | 42.23B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.06 | 19.33B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
152.42 | 15.43B | 2.24B | 385.90M | 440.10M | 3.73 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Lake Street | Buy |
| 2024-02-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-05-24 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-08-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 開始されました | SVB Leerink | Outperform |
| 2019-08-26 | 再開されました | Credit Suisse | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
| 2019-04-17 | 開始されました | Oppenheimer | Outperform |
| 2019-04-11 | 開始されました | SunTrust | Buy |
すべてを表示
Organogenesis Holdings Inc (ORGO) 最新ニュース
A Look At Organogenesis Holdings Inc (ORGO) Stock Performance - Stocks Register
JPMorgan Chase & Co. Increases Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by JPMorgan Chase & Co. - Defense World
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 - The Manila Times
Organogenesis to Report Q4 and Full Year 2024 Financial Results on February 27 - StockTitan
Organogenesis (ORGO) Stock Price, News & Analysis - MarketBeat
Analysts Issue Forecasts for Organogenesis FY2025 Earnings - Defense World
Analysts Offer Predictions for Organogenesis FY2025 Earnings - MarketBeat
Barclays PLC Acquires 67,855 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Has $9.44 Million Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Purchases 1,035,120 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Leads These 3 US Penny Stocks - Simply Wall St
Jane Street Group LLC Lowers Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Boosted by Barclays PLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by State Street Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Up 29.1% in December - MarketBeat
Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals
Fmr LLC Buys 44,199 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Commerce Corp. grants tax agreement to Smithfield - Providence Business News
Gary S. Gillheeney Sells 5,585 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) CEO Gary S. Gillheeney Sells 55,615 Shares - MarketBeat
Organogenesis CEO Gary Gillheeney sells shares worth $206,358 - Investing.com
US Penny Stocks To Consider In December 2024 - Simply Wall St
Charles Schwab Investment Management Inc. Grows Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by Verition Fund Management LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Cut by BNP Paribas Financial Markets - Defense World
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 - Investing.com
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 By Investing.com - Investing.com UK
Wound Care Market 2024By Industry Outlook, Future Trends, - openPR
Organogenesis CEO Gillheeney sells shares worth $211,721 - Investing.com India
Organogenesis CEO Gillheeney sells shares worth $211,721 By Investing.com - Investing.com Nigeria
Jacobs Levy Equity Management Inc. Lowers Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (NASDAQ: ORGO) -0.26% Decline Turns Investors Away - Stocks Register
Organogenesis Holdings Inc. announces an Equity Buyback for 500,000 shares, for $2.03 million. - Marketscreener.com
Organogenesis announces stock repurchase at trailing average price By Investing.com - Investing.com Australia
Organogenesis announces stock repurchase at trailing average price - Investing.com
Advantage Alpha Capital Partners LP Trims Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Mass. firm signs lease for former Rubius facility in Smithfield - Providence Business News
News | Massachusetts-based regenerative tissue medical firm expands in Rhode Island - CoStar Group
News | Massachusetts-based regenerative medical firm expands in Rhode Island - CoStar Group
Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times
Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com
Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan
Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com
Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle
FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat
Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Organogenesis Commends Final LCDs - The Manila Times
Organogenesis Holdings Inc (ORGO) 財務データ
収益
当期純利益
現金流量
EPS
1.76%
1.79%
大文字化:
|
ボリューム (24 時間):